Heterotrimeric G proteins are pivotal regulators of myocardial contractility. In addition to the receptor-induced GDP/GTP exchange, G protein ␣ subunits can be activated by a phosphate transfer via a plasma membrane-associated complex of nucleoside diphosphate kinase B (NDPK B) and G protein ␤␥-dimers (G␤␥). To investigate the physiological role of this phosphate transfer in cardiomyocytes, we generated a G␤ 1 ␥ 2 -dimer carrying a single amino acid exchange at the intermediately phosphorylated His-266 in the ␤ 1 subunit (G␤ 1 H266L␥ 2 ). Recombinantly expressed G␤ 1 H266L␥ 2 were integrated into heterotrimeric G proteins in rat cardiomyocytes but were deficient in intermediate G␤ phosphorylation. Compared with wild-type G␤ 1 ␥ 2 (G␤ 1 WT␥ 2 ), overexpression of G␤ 1 H266L␥ 2 suppressed basal cAMP formation up to 55%. A similar decrease in basal cAMP production occurred when the formation of NDPK B/G␤␥ complexes was attenuated by siRNA-mediated NDPK B knockdown. In adult rat cardiomyocytes expressing G␤ 1 H266L␥ 2 , the basal contractility was suppressed by Ϸ50% which correlated to similarly reduced basal cAMP levels and reduced Ser16-phosphorylation of phospholamban. In the presence of the ␤-adrenoceptor agonist isoproterenol, the total cAMP formation and contractility were significantly lower in G␤ 1 H266L␥ 2 than in G␤ 1 WT␥ 2 expressing cardiomyocytes. However, the relative isoproterenol-induced increased was not affected by G␤ 1 H266L␥ 2 . We conclude that the receptor-independent activation of G proteins via NDPK B/G␤␥ complexes requires the intermediate phosphorylation of G protein ␤ subunits at His-266. Our results highlight the histidine kinase activity of NDPK B for G␤ and demonstrate its contribution to the receptor-independent regulation of cAMP synthesis and contractility in intact cardiomyocytes.
H eterotrimeric GTP-binding proteins (G proteins) are important mediators in many signal transduction pathways. 1 In cardiomyocytes, activation of G s and G i proteins via G protein-coupled receptors (GPCR) regulates intracellular cAMP levels, which control myocardial contractility by activation of protein kinase A (PKA) pathway and alteration in Ca 2ϩ transients. 2, 3 It is generally accepted that heterotrimeric G proteins are activated by a GPCR-induced GDP/GTP exchange at the G␣ subunit, followed by regulation of specific effector molecules, such as adenylyl cyclase (AC), phospholipase C␤ or ion channels. 1, 4 In addition, GTP formation by nucleoside diphosphate kinases (NDPKs) contributes to the activation of G proteins, a concept first described by Kimura and coworkers. 5 Recent data suggest that a NDPK-dependent phosphate relay acts as alternative pathway to the GPCR-induced GDP/GTP exchange. 6, 7 NDPKs, encoded by nm23 genes, represent an evolutionarily and structurally conserved family of multifunctional proteins that have been implicated in various cellular processes, including tumor metastasis, 8, 9 apoptosis, 10 endocytosis, 11 and gene regulation. 12 In eukaryotic cells, the major isoforms NDPK A, B, and C (17 to 21 kDa) are characterized by their enzymatic activity, ie, generation of nucleoside triphosphates from the respective diphosphates through a high-energy His-118 intermediate. 13 Only a small fraction of NDPK is associated with the plasma membrane. However, it has been reported that the NDPK content at the plasma membrane is increased by 300% in hearts from patients with congestive heart failure 14 and in hearts from rats with isoproterenol-induced hypertrophy. 15 We have recently shown that G s proteins can be activated by a plasma membrane-associated complex of nucleoside diphosphate kinase B (NDPK B) and the ␤␥ subunit of G proteins. 6, 7 The complex formation of NDPK B with G␤␥ dimers was detected in different tissues. Within this complex, NDPK B apparently phosphorylates G␤ at His-266. The phosphate is of high energy and can be transferred onto GDP. The formed GTP then subsequently activates G s and G i proteins. 16, 17 In accordance with this mechanism stable overexpression of NDPK B, but not of its catalytically inactive mutant NDPK B-H118N or NDPK A, largely enhanced G␣ s -dependent cAMP formation in living cells. 7 To analyze the contribution of the NDPK B/G␤␥ complex to G protein activation in cardiomyocytes, we generated a mutant of the G protein ␤ 1 subunit, in which the intermediately phosphorylated His-266 is substituted by leucine (G␤ 1 H266L). We show that adenoviral overexpression of G␤ 1 H266L␥ 2 -dimers as well as siRNA-induced depletion of NDPK B reduced receptor-independent G␣ s activation in cardiomyocytes. Thus, the NDPK B/G␤␥-mediated phosphate transfer is apparently involved in the regulation of receptor-independent cAMP synthesis and contractility in cardiomyocytes.
Materials and Methods

Generation of Recombinant Adenoviruses
Human cDNA of G␤ 1 and G␥ 2 were obtained from UMR cDNA Resource Center, University of Missouri-Rolla. Site directed mutagenesis (QuikChange, Stratagene) was performed to introduce leucine for histidine at position 266 of G␤ 1 according to the manufactures protocol. cDNA encoding G␤ 1 was subcloned into the pShuttle-IRES-hrGFP-1 vector (Stratagene). G␤ 1 in conjunction with the internal ribosome entry site (IRES) was isolated from pShuttle and subcloned into the pAdTrack-CMV vector. 18 G␥ 2 was inserted into this construct downstream the IRES to obtain bicistronic mRNA. Recombinant adenoviruses were generated by homologous recombination with the adenoviral backbone vector pAd-Easy-1. 18 Adenoviruses encoding for GFP alone and the long form of rat G␣ s has been described. 7
Isolation and Infection of Rat Cardiomyocytes
Culture of immortalized neonatal rat cardiomyocytes (H10 cells) and generation of stably transfected cell clones (NDPKϩ cells) has been described. 7 Neonatal rat cardiomyocytes (NRCM) were isolated as described 19 and were infected with the indicated multiplicity of infection (MOI) under serum-free conditions 48 hours after plating and subsequently cultured supplemented with 2% FCS for 48 hours. Adult rat cardiomyocytes (ARCM) were isolated from Sprague-Dawley rats using a collagenase digestion method 19 and were infected 1 hour after plating and further cultured for 48 hours in a HEPES-modified medium 199 (M199, Sigma S7528, supplemented with 5 mmol/L taurine, 5 mmol/L carnitine, 5 mmol/L creatine, 5 mmol/L N-mercaptoproprionyl glycine, 0.1 mol/L insulin, 10,000 U/mL penicillin and 10 mg/mL streptomycin, pH 7.25).
NDPK Depletion in NRCM
Knockdown was performed by a sequential, double transfection with siRNA duplexes (100 nmol/L) as described 20 using Lipo-fectamine2000 reagent (Invitrogen). siRNAs were directed against the following target sequences 10, 20 : NDPK A#1: GGATTCCGCCT-GGTTGGTT, NDPK B#1: GGGGTTCCGCCTGGTGGCC, NDPK B#2: AACTGATTGACTATAAGTCTT. Control siRNA (si-Control) was a scrambled siRNA (Ambion).
Measurement of Contractile Parameters
Contractile parameters in ARCM were obtained 48 hours after adenoviral gene transfer by video edge detection, as described previously 21 at 1.8 mmol/L [Ca 2ϩ ] e and at 0.5 Hz field stimulation.
Phosphorylation of G␤ and NDPK in Cell Membranes
Preparation of cell membranes and phosphorylation of G␤ was performed exactly as described previously. 22
Measurement of cAMP Levels
Generation of cAMP was assayed in serum-free medium containing 1 mmol/L 3-isobutyl-1-methylxanthine (IBMX) in the presence of propranolol or isoproterenol (ISO) with 100 mol/L ascorbic acid as indicated for 20 minutes as previously described 22 using a cAMP immunoassay (R&D Systems).
Western Blotting
Western blotting was performed according to standard procedures. 22 Immunodetection was performed by using specific primary antibodies against G␣ s (Gramsch), G␤ com , G␤ 1 , G␥ 2 , NDPK (Santa Cruz), G␣ i2 (PerkinElmer Life Science), calsequestrin (Swant), pan-Cadherin (Abcam), Ser16-phospho-phospholamban (Upstate) and ␤-actin (Sigma). Specific NDPK B antibody was a kind gift of Dr Ioan Lascu, Bordeaux. Detection was performed with suitable secondary antibodies and an enhanced chemiluminescence (ECL) reagent (Pierce).
Coimmunoprecipitation
Cells were lysed in immunoprecipitation buffer (10 mmol/L Tris-HCl, pH 7.4, 0.1% Triton X-100, 150 mmol/L NaCl, 1 mmol/L PMSF and protease inhibitors) 48 hour after infection. Coimmunoprecipitation was performed as described 7 using anti-G␣ s antibody and the precipitate was immunoblotted for G␣ s and G␤.
Statistical Analysis
All results were expressed as meanϮSEM. We performed statistical analysis using one-way ANOVA with Bonferroni post hoc test or t-tests as appropriate. PϽ0.05 was considered statistically significant.
Results
Integration of Phosphodeficient G␤ 1 H266L␥ 2 Dimers Into Heterotrimeric G s Proteins
To analyze the importance of the NDPK B/G␤␥ complex for G protein activation, we constructed a mutant of the G protein ␤ 1 subunit, in which the intermediately phosphorylated His-266 residue was changed to a leucine (G␤ 1 H266L). We generated biscistronic adenoviral vectors encoding wild-type G␤ 1 (G␤ 1 WT␥ 2 ) or H266L-mutated G␤ 1 (G␤ 1 H266L␥ 2 ) in conjunction with G␥ 2 , to allow for formation of G␤␥-dimers in the target cell. G␤ 1 WT␥ 2 or G␤ 1 H266L␥ 2 dimers were adenovirally overexpressed in H10 cells and NRCM. An adenovirus encoding GFP alone (AdGFP) served as additional control. Overexpressed G␤ 1 WT␥ 2 and G␤ 1 H266L␥ 2 were localized in the membrane fraction of infected myocytes ( Figure 1A ), which is in accordance with the known localization of correctly formed and folded G␤␥ dimers. 23 The content of the membrane in G␣ s and G␣ i was slightly increased, most likely because of enhanced heterotrimer formation.
To verify the integration of overexpressed wild-type and mutated G␤ 1 ␥ 2 -dimers into heterotrimeric G proteins coimmunoprecipitations were performed in NRCM infected with AdG␤ 1 ␥ 2 . As shown in Figure 1B , an anti-G␣ s -antibody coprecipitated similar amounts of G␤ 1 WT and G␤ 1 H266L bound to endogenous G␣ s . When G␣ s -expression was increased by AdG␣ s increasing amounts of overexpressed G␤ 1 WT and G␤ 1 H266L were coprecipitated. These findings indicate a competition of the overexpressed G␤ 1 ␥ 2 -dimers with endogenous G␤␥ for heterotrimer formation with G␣ s .
To test whether G␤ 1 H266L␥ 2 is a substrate for the NDPK B phosphorylation of G␤, cell membranes were phosphorylated with [␥-32 P]GTP. As shown in the autoradiography ( Figure 1C ), overexpression of G␤ 1 WT␥ 2 increased the intermediate G␤-phosphorylation (2.1Ϯ0.2 -fold, normalized to GFP control, nϭ3). In contrast, G␤-phosphorylation did not increase above endogenous level when G␤ 1 H266L␥ 2 was overexpressed ( Figure 1C ). These results confirm that residue His-266 is the phosphorylated amino acid in G␤ 1 and demonstrate that H266L-mutated G␤ 1 cannot be phosphorylated by NDPK B.
In summary, these data indicate a similar efficient incorporation of the phosphodeficient G␤ 1 H266L into heterotrimeric G s as G␤ 1 WT, providing an efficient tool to study the effect of this point mutation on G protein activity.
NDPK B-Dependent Suppression of Basal, Receptor-Independent cAMP Synthesis by Overexpression of G␤ 1 H266L␥ 2
Previous findings in H10 cells 7 suggest that NDPK B/G␤␥mediated phosphate transfer is a mechanism for receptorindependent G protein activation. Here we studied the effect of a His to Leu replacement at position 266 in G␤ 1 on NDPK B/G␤␥-mediated G s activation, using cAMP as reporter. Experiments were performed in H10-WT cells and H10 cells with a 3-fold overexpression of NDPK B (NDPKϩ cells 7 ). cAMP production was determined in the presence of the ␤-adrenoceptor (␤AR) inverse agonist propranolol to block spontaneous or constitutive ␤AR activity. Infection of H10 cells with increasing doses of AdG␣ s combined with either AdG␤ 1 WT␥ 2 or AdG␤ 1 H266L␥ 2 resulted in similar amounts of protein expression ( Figure 2A ). Overexpression of the G␤ 1 ␥ 2 variants did not alter of NDPK B expression ( Figure 2A ) nor the total NDPK activity in these cells (GFP: 93.7Ϯ4.3, G␤ 1 WT␥ 2 : 90.5Ϯ3.6, G␤ 1 H266L␥ 2 : 91.7Ϯ4.3 nmol/min*mg). In H10-WT cells, increasing amounts of G␣ s were associated with a linear increase cAMP accumulation. However, coexpression of G␤ 1 H266L␥ 2 reduced this effect by Ϸ30% compared with G␤ 1 WT␥ 2 at each level of G␣ s ( Figure 2B ). In NDPKϩ cells, the elevated NDPK B content increased the G␣ s -mediated cAMP synthesis 7 and enhanced the inhibitory effect of G␤ 1 H266L␥ 2 ( Figure 2C ). At the highest G␣ s expression (MOI 100), the cAMP content in G␤ 1 H266L␥ 2 -infected NDPKϩ cells amounted to 45.0Ϯ3.7% (nϭ4, PϽ0.001) of that seen in G␤ 1 WT␥ 2 -infected cells. Thus, the observed difference between G␤ 1 WT␥ 2 and G␤ 1 H266L␥ 2 overexpressing cells in basal cAMP synthesis apparently depends on both the level of G␣ s and NDPK B.
H10 cells are derived from NRCM, but are altered by the immortalization. Therefore, we performed a similar coexpression of G␣ s with either G␤ 1 WT␥ 2 or G␤ 1 H266L␥ 2 in freshly isolated NRCM and determined the cAMP accumulation in the presence of propranolol. Note that NRCM are more sensitive to adenoviral infection than H10 cells. Thus, for similar effective adenoviral infections a 10-fold reduced MOI was sufficient ( Figure 3A ). Overexpression of G␤ 1 WT␥ 2 did not alter basal cAMP compared with GFP controls (GFP: 60.7Ϯ7 pmol/mg; G␤ 1 WT␥ 2 : 57.7Ϯ10 pmol/mg). In NRCM, we observed two effects of G␤␥ overexpression on cAMP formation: (1) when compared with the expression of G␣ s alone ( Figure 3B ), coexpression of G␣ s and G␤␥ dimers resulted in a strong reduction (89Ϯ3%) in basal cAMP synthesis, which is because of the well known formation of inactive G␣ s ␤␥ heterotrimers (see Figure  1B ) in the absence of a stimulated receptor 24 ; and (2) beyond this expected effect, overexpression of G␤ 1 H266L␥ 2 induced a further significant suppression of the receptor-independent cAMP synthesis. Similarly to NDPKϩ cells, cAMP levels of G␤ 1 H266L␥ 2 myocytes were reduced by 30% to 50% compared with G␤ 1 WT␥ 2 myocytes in a G␣ s level dependent manner ( Figure 3C ).
Specific Depletion of NDPK B Decreases Basal cAMP Synthesis in NRCM
To interfere with the phosphate transfer reactions by NDPK B/G␤␥ complexes using a different approach, we performed Overexpression of G␤␥ dimers and NDPK-mediated phosphorylation of G protein ␤ subunits in cardiomyocytes. A, Cell membranes prepared 48 hour after infection with adenoviruses encoding GFP, G␤ 1 WT␥ 2 or G␤ 1 H266L␥ 2 were subjected to immunoblot analysis with specific antibodies for G␤ 1 , G␥ 2 , G s and G i2 . Similar data were obtained in H10 cells and NRCM. B, Integration of overexpressed G␤ 1 ␥ 2 -dimers, wild-type or H266Lmutant, into heterotrimeric G s proteins was confirmed by immunoprecipitation (IP) with an anti-G␣ s antibody from NRCM lysates infected as indicated. The precipitates were probed for G␤ with a G␤ 1 -and a more sensitive G␤ com -specific antibody. C, Cell membranes were phosphorylated with [␥-32 P]GTP for 1 and 3 minutes at 30°C. A representative autoradiography after SDS-Page of three independent experiments is shown. Phosphorylated G␤ and autophosphorylated NDPK are indicated.
siRNA-mediated knockdown of NDPK isoforms in NRCM.
A sequential, double transfection with siRNA duplexes targeting NDPK A (si-NDPK A) and B (si-NDPK B#1, B#2) specifically reduced the expression of the targeted NDPK isoform by approximately 70% ( Figure 4A ). Depletion of NDPK B, but not of NDPK A, resulted in significantly diminished cAMP levels (si-NDPK B#2: 47.8Ϯ2.6% of control, nϭ3, PϽ0.01) which correlated with the reduction in NDPK B expression ( Figure 4B ). This effect is likely because of the attenuation of NDPK B/G␤␥ complex formation by NDPK B depletion.
Suppression of Basal, Receptor-Independent Contractility of Cardiomyocytes by Overexpression of G␤ 1 H266L␥ 2
Changes in cAMP formation influence contractility via activation of PKA and subsequent modulation of Ca 2ϩ -transients by phosphorylation of proteins involved in Ca 2ϩ -handling, eg, phospholamban (PLB). 25 We therefore studied the impact of impaired phosphorylation of G␤ at His-266 on cAMP levels, PLB phosphorylation and contractility in ARCM. Efficient transduction with adenoviruses encoding GFP, G␤ 1 WT␥ 2 or G␤ 1 H266L␥ 2 was monitored by GFP expression driven by an independent CMV promoter ( Figure 5A ). The viability of the infected cells (65% to 70% after 48 hour, detected by trypan blue exclusion) was similar for all used adenoviruses. Immunoblots of whole cell lysates confirmed similar levels of overexpression of G␤ 1 WT␥ 2 or G␤ 1 H266L␥ 2 at the indicated MOI ( Figure 5A ). Concordant with H10 cells and NRCM, basal cAMP levels were significantly reduced in ARCM expressing G␤ 1 H266L␥ 2 by 35Ϯ2% (nϭ5, PϽ0.05) compared G␤ 1 WT␥ 2 ( Figure 5B ). G␤ 1 H266L␥ 2 overexpression also suppressed PLB phosphorylation by 40Ϯ9% (nϭ3, PϽ0.05) relative to control myocytes ( Figure 5C ). Singlemyocyte contractility was analyzed using video edge detection in the presence of propranolol. 19 Compared with AdGFPinfected cells (MOI 10 4 ), uninfected ARCM exhibited no significant differences in the contraction parameters analyzed either with or without 100 nmol/L propranolol (data not shown). Overexpression of G␤ 1 WT␥ 2 -dimers slightly, but significantly increased myocyte contractility when compared with AdGFP-infected myocytes (fractional shortening: G␤ 1 WT␥ 2 versus GFP: 13.3Ϯ0.3% versus 10.7Ϯ0.3%, nϭ81 to 95, PϽ0.05) ( Figure 5D ). This might reflect a cAMPindependent effect of the well known G␤␥ interaction with cardiac ion channels or other G␤␥ regulated pathways. Overexpression of G␤ 1 H266L␥ 2 , however, significantly reduced myocyte contractility compared with G␤ 1 WT␥ 2 and GFP overexpressing myocytes. At the highest expression level of G␤ 1 ␥ 2 (MOI 10 4 ), basal fractional shortening in G␤ 1 H266L␥ 2 expressing myocytes (7.4Ϯ0.4%) was reduced to Ϸ50% of that observed in G␤ 1 WT␥ 2 overexpressing controls (13.3Ϯ0.3%, nϭ81, PϽ0.01). Similar decreases in maximum rates of myocytes shortening (Ϫdl/dt) and relengthening (ϩdl/dt) were found in G␤ 1 H266L␥ 2 myocytes ( Figure 5D ). As observed before (Figure 2 Thus, an impaired phosphorylation of G␤ 1 at His-266 in cardiomyocytes leads to a substantial suppression of basal cAMP, PLB phosphorylation and receptor-independent contractility.
Impact of G␤ 1 H266L␥ 2 on cAMP Formation and Cardiomyocyte Contractility in the Presence of Isoproterenol
The activation of G proteins via ␤ARs plays a key role in the regulation of cardiac contractility. 3 We therefore analyzed the induction of cAMP synthesis and contractility in response to the ␤AR agonist isoproterenol (ISO) in H10 cells, NRCM, and ARCM overexpressing G␤ 1 WT␥ 2 or G␤ 1 H266L␥ 2 at a similar level. The total values of cAMP formation in the presence of ISO were significantly lower by Ϸ30% in G␤ 1 H266L␥ 2 expressing cells compared with G␤ 1 WT␥ 2 (Figure 6A-C) . Nevertheless, both G␤ 1 WT␥ 2 and G␤ 1 H266L␥ 2 expressing cells exhibited similar responses to ISO stimulation in either cell type, when related to the different basal cAMP levels ( Figure 6A -C, insets, -fold stimulation).
Contraction amplitudes of ARCM increased up to 2-fold in response to ISO ( Figure 6D ). When compared with AdGFPor AdG␤ 1 WT␥ 2 -infected myocytes the ISO-induced increase in contraction ( Figure 6D , ⌬, ISO-Basal) was virtually unchanged in G␤ 1 H266L␥ 2 expressing cells. In accordance to the cAMP data, the absolute contraction amplitudes in the presence of ISO were significantly attenuated in AdG␤ 1 H266L␥ 2 -infected myocytes, which likely reflects the reduced basal contractility in these cells ( Figure 6D) . In addition to these functional data, we used a rather artificial in vitro system, ie, baculovirus-mediated expression of G␣ s ␤ 1 H266L␥ 2 , G␣ s ␤ 1 WT␥ 2 and ␤AR in Sf9 insect cells, to directly measure the ␤AR-induced GDP/GTP exchange (supplemental Figure II in the online data supplement). We observed no difference in ␤AR-induced G␣ s ␤ 1 H266L␥ 2 or G␣ s ␤ 1 WT␥ 2 activation in Sf9 cells.
Taken together, these findings indicate that an impaired phosphorylation of G␤ 1 at His-266 in cardiomyocytes does not compromise G protein activation by receptor-stimulated GDP/GTP exchange but significantly attenuates total G protein activity also in the presence of a receptor agonist.
Discussion
According to the concept first described by Gilman 4 heterotrimeric G proteins are transducers of extracellular signals from cell surface G protein-coupled receptors (GPCR) to intracellular effectors. We previously complemented this concept by showing that NDPK B is a receptor-independent activator of G proteins in living cells. 7 Within a NDPK B/G␤␥ complex, the NDPK B apparently transfers a high energetic phosphate via intermediately phosphorylated G protein ␤-subunits specifically onto GDP. This GTP formation induces the activation of the G protein. The intermediately phosphorylated amino acid was identified as His-266 in G␤. 6 In the present study, we confirmed the identity of His-266 as the phosphorylated amino acid (see Figure 1C ). The substitution of leucine for histidine 266 in G␤ 1 led to the formation of a G␤ 1 ␥ 2 -dimer, which in contrast to wild-type G␤ 1 ␥ 2 could no longer be phosphorylated by NDPK B. We obtained several lines of evidence that the G␤ 1 H266L␥ 2dimer forms regular heterotrimers with G␣ s and that the activation of such heterotrimers via the classical GPCRinduced GDP/GTP exchange is unaffected. First, G␤ 1 WT␥ 2 and G␤ 1 H266L␥ 2 could be coimmunoprecipitated with endogenous or overexpressed G␣ s to a similar extent. Second, although the total values in response to ISO were reduced by G␤ 1 H266L␥ 2 , the ISO-induced stimulation in cAMP synthesis and contractility were comparable in myocytes expressing G␤ 1 WT␥ 2 or G␤ 1 H266L␥ 2 . Particularly, when related to the different baseline levels in myocytes expressing G␤ 1 WT␥ 2 or G␤ 1 H266L␥ 2 virtually no alterations in the extent (x-fold) or concentration dependency of the stimulation by ISO occurred. Third, baculovirus-mediated expression of G␤ 1 H266L␥ 2 or G␤ 1 WT␥ 2 similarly supported the ␤ARinduced activation of G␣ s in Sf9 insect cells. Unlike the mutation of NDPK B at His-118, 26 which interferes with all processes requiring the catalytic activity of NDPK B, the H266L-mutant of G␤ 1 therefore provided a tool to selectively disrupt NDPK B-mediated G protein activation without apparently interfering with processes requiring NDPK B activity on the one hand, or GPCR-induced GDP/GTP exchange on the other.
Whereas receptor-induced control of cAMP synthesis and the resulting response in contractility have been studied in great detail, 2, 27 little is known about the control of basal, receptor-independent cAMP formation in and contractility of cardiomyocytes. As our previous data 6,7,15 indicated a contribution of the NDPK B/G␤␥ complex to basal, receptorindependent activation of heterotrimeric G proteins, we adenovirally overexpressed G␤ 1 H266L␥ 2 and G␤ 1 WT␥ 2 in H10 cells, NRCM and ARCM to study the ability of the H266L-mutated G␤ 1 to interfere with the receptorindependent activation of G␣ s . To exclude influences of a possible constitutive activity of ␤ARs (for review see Ref. 28 ) assays were performed in the presence of the inverse ␤AR agonist propranolol. Overexpression of G␤␥ in cells may induce several effects. In accordance with data in the literature 29, 30 we observed a slight increase in the G s and G i content in the membrane fraction (see Figure 1A) . Moreover, free G␤␥-dimers can induce a costimulation of G␤␥-sensitive AC isoforms in the presence of activated G␣ s 31 which would perturb cAMP formation and contractility measurement. Nevertheless, the major cardiac AC isoforms type V and VI 32, 33 are not costimulated by G␤␥. Accordingly, no increase in cAMP was observed in H10 cells, NRCM and ARCM. However, compared with the expression of G␣ s alone, we observed a strong reduction in cAMP content when G␤␥ is coexpressed with G␣ s (see Figure 3B ). This prominent decrease likely represents the well known formation of inactive heterotrimers (see also Figure 1B ) in which the G␣ subunits are stabilized in their GDP-bound form by G␤␥ binding. 24 As G␤ 1 WT␥ 2 and G␤ 1 H266L␥ 2 did not differ in their ability to form G␣ s ␤␥ heterotrimers (see Figure 1B) , we conclude that the additional reduction in cAMP synthesis and the suppression of basal contractility detected when His-266 in G␤ 1 is replaced by leucine (see Figure 2 , 3, and 5) reflects the lack of activation of G␣ s via NDPK B/G␤␥-mediated phosphate transfer. This interpretation is further supported by the data showing that the decrease in cAMP and contractility is further enhanced by elevated expression of NDPK B (see Figure 2 ) and G␤ 1 ␥ 2 dimers (see Figure 5 ), respectively. Apparently, G␤ 1 H266L␥ 2 is effectively competing with endogenous G␤␥ for complex formation with NDPK B and thus the impact of G␤ 1 H266L␥ 2 on cAMP synthesis is more pronounced in NDPKϩ cells. Moreover, reducing the formation of NDPK B/G␤␥ complexes by siRNA-mediated depletion of NDPK B content (see Figure 4 ) suppressed the basal cAMP production in NRCM. These observations are in line with previous data obtained in H10 cells overexpressing NDPK B or its catalytic inactive H118N-mutant. 7 In addition, increased expression of G␣ s enhanced the difference between G␤ 1 H266L␥ 2 and G␤ 1 WT␥ 2 overexpressing myocytes (see Figure 2 , 3, and supplemental Figure I available at http:// circres.ahajournals.org). Therefore, the data at large indicate that the contribution of the NDPK B/G␤␥-mediated phosphotransfer to basal G␣ s activation is the stronger the more G␣ s /G␤␥/NDPK B complexes are able to form. Cellular depletion of the complex partner NDPK B or incorporation of mutants defective in phosphotransfer (NDPK B-H118N 7 or even more specific G␤ 1 H266L) into such complexes blocks this activation pathway. Noteworthy, also effectors which might be activated directly by G␣ s and contribute to basal contractility in cardiomyocytes, eg, L-type Ca 2ϩ channels, 34 are potentially regulated by G␣ s /G␤␥/NDPK B complexes.
If the formation of such G␣␤␥/NDPK B complexes plays a role in basal G protein activity, the question is raised, whether its contribution is regulated itself. In hearts from patients with severe congestive heart failure a 3-fold elevated content and activity of NDPK in plasma membranes was detected. 14 This elevation was diminished in patients treated with a ␤AR antagonist. Chronic treatment of rats with the ␤AR agonist ISO, induced an increase in plasma membranebound NDPK, 15 suggesting chronic ␤AR activation as a mechanism for regulation of the NDPK membrane content. As G i protein expression is also increased in heart failure, 35 the higher NDPK and G i content may lead to an increased formation of G␣ i ␤␥/NDPK B complexes, which cause diminished basal cAMP formation and, thus, decreased contractility. 35 In this context, it is noteworthy that NDPK B apparently acts as a (G protein-) histidine kinase in that complex. Thus, it might be of particular interest that the first identified eukaryotic phosphohistidine phosphatase (PHP) 36 specifically dephosphorylates G␤, but not NDPK B, in reconstituted systems and in H10 cells membranes. 37 Therefore, PHP might be a candidate for an endogenous regulator of basal NDPKdependent G protein activation targeting the same specific step in the activation, which we artificially suppressed by mutating His-266 in G␤ 1 . Although currently no data are available with regard to His-266 phosphorylation of G␤subunits under pathophysiological conditions, NDPK is playing a role in human heart failure 14 and rat heart hypertrophy. 15 Therefore, the modulation of His-266 phosphorylation of G␤ could be a potential novel target for therapeutical interventions in heart failure.
In conclusion, our data show that the basal, receptorindependent activation of cardiac G s proteins via NDPK B/G␤␥ complexes requires the intermediate phosphorylation of G protein ␤ subunits at His-266. The mutation of this single amino acid blocks this pathway, followed by reduced myocyte cAMP levels, phospholamban phosphorylation and contraction amplitudes. Our results therefore highlight a novel role of NDPK B as a mammalian G protein-histidine kinase that regulates cAMP synthesis in and contractility of cardiomyocytes by a mechanism bypassing the receptorinduced GDP/GTP exchange at G␣ s .
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